Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
27.66
+0.52 (1.92%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Employees
As of December 31, 2024, Agios Pharmaceuticals had 488 total employees, including 486 full-time and 2 part-time employees. The number of employees increased by 102 or 26.42% compared to the previous year.
Employees
488
Change (1Y)
102
Growth (1Y)
26.42%
Revenue / Employee
$74,791
Profits / Employee
$1,380,584
Market Cap
1.58B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
AGIO News
- 1 day ago - Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025 - GlobeNewsWire
- 6 weeks ago - Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer - GlobeNewsWire
- 6 weeks ago - Agios to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - GlobeNewsWire
- 2 months ago - Agios Pharmaceuticals, Inc. (AGIO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Agios Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Agios' Phase 3 ACTIVATE-Kids Study of Mitapivat in Children with Pyruvate Kinase (PK) Deficiency Not Regularly Transfused Met Primary Endpoint - GlobeNewsWire
- 2 months ago - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2024 Financial Results on February 13, 2025 - GlobeNewsWire